Emmanuel Nedoschill

Emmanuel Nedoschill

Auto-generated profile, based on publicly available information

Emmanuel Nedoschill

Department of Pediatrics and Adolescent Medicine University Hospital Erlangen Friedrich‐Alexander‐Universität (FAU) Erlangen‐Nürnberg 91054 Erlangen Germany

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2024 in Med
Verified
Journal Article
Open access
ENEmmanuel Nedoschill
Emmanuel Nedoschill
AWAlexandra L. Wagner
Alexandra L. Wagner
VDVera Danko
Vera Danko
ABAdrian Buehler
Adrian Buehler
RRRoman Raming
Roman Raming
ARAdrian Regensburger
Adrian Regensburger
Spinal muscular atrophy is a progressive neuromuscular disorder and among the most frequent genetic causes of infant mortality. While recent advancements in gene therapy provide the potential to ameliorate the disease severity, there is currently no modality in clinical use to visualize dynamic pathophysiological changes in disease progression and regression after therapy. In this prospective diagnostic clinical study, ten pediatric patients with spinal muscular atrophy and ten age- and sex-matched controls have been examined with three-dimensional optoacoustic imaging and clinical standard examinations to compare the spectral profile of muscle tissue and correlate it with motor function (ClinicalTrials.gov: NCT04115475). We observed a reduced optoacoustic signal in muscle tissue of pediatric patients with spinal muscular atrophy. The reduction in signal intensity correlated with disease severity as assessed by grayscale ultrasound and standard motor function tests. In a cohort of patients who received disease-modifying therapy prior to the study, the optoacoustic signal intensity was similar to healthy controls. This translational study provides early evidence that three-dimensional optoacoustic imaging could have clinical implications in monitoring disease activity in spinal muscular atrophy. By visualizing and quantifying molecular changes in muscle tissue, disease progression and effects of gene therapy can be assessed in real time. The project was funded by ELAN Fonds (P055) at the University Hospital of the Friedrich-Alexander-Universität (FAU) Erlangen-Nurnberg to A.P.R.

22 October 2024 in Advanced Science
Verified
Journal Article
Open access
ABAdrian Buehler
Adrian Buehler
EBEmma L. Brown
Emma L. Brown
ENEmmanuel Nedoschill
Emmanuel Nedoschill
Markus EcksteinMarkus Eckstein
Markus Eckstein
PLPetra Ludwig
Petra Ludwig
ARAdrian Regensburger
Adrian Regensburger
The analysis of vascular morphology and functionality enables the assessment of disease activity and therapeutic effects in various pathologies. Raster‐scanning optoacoustic mesoscopy (RSOM) is an imaging modality that enables the visualization of superficial vascular networks in vivo. In murine models of colitis, deep vascular networks in the colon wall can be visualized by transrectal absorber guide raster‐scanning optoacoustic mesoscopy (TAG‐RSOM). In order to accelerate the implementation of this technology in translational studies of inflammatory bowel disease, an image‐processing pipeline for TAG‐RSOM data has been developed. Using optoacoustic data from a murine model of chemically‐induced colitis, different image segmentation methods are compared for visualization and quantification of deep vascular patterns in terms of vascular network length and complexity, blood volume, and vessel diameter. The presented image‐processing pipeline for TAG‐RSOM enables label‐free in vivo assessment of changes in the vascular network in murine colitis with broad applications for inflammatory bowel disease research.

19 December 2023 in Research Square
Verified
Preprint
Open access
PDF file
FKFerdinand Knieling
Ferdinand Knieling
SSSimone Schwarz
Simone Schwarz
LDLouise Denis
Louise Denis
ENEmmanuel Nedoschill
Emmanuel Nedoschill
ABAdrian Buehler
Adrian Buehler
AHAlina Hilger
Alina Hilger
During the first days of neonatal growth, the central nervous system (CNS) develops self-regulatory mechanisms to ensure constant cerebral perfusion. However, this vascular neogenesis takes place at a microscopic scale that cannot be observed with current clinical imaging techniques. Ultrasound localization microscopy (ULM) allows us to observe micro-vessels of the order of a few microns at depths of several centimeters. This can be done using conventional clinical ultrasound scanners and contrast sequences (CEUS). In this study, we used ULM to observe the human microvasculature in neonatal patients undergoing treatment for life-threatening malformations forming direct connections between the cerebral arterial and venous systems. We observed that neuroendovascular treatment of neonatal arteriovenous malformations caused remodeling and reorganization of the cerebral vasculature by also activating corticomedullary vascular connections. ULM has thus enabled us to follow microstructural vascular changes in human neonates with high spatio-temporal resolution. ULM may provide a novel clinical translatable tool, particularly including cerebral imaging in very young patients. One-Sentence Summary: Ultrasound localization microscopy (ULM) reveals vascular reorganization in human neonates after catheter-based treatments.